Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes

DSpace/Manakin Repository

Open Research Exeter (ORE)

Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes

Please use this identifier to cite or link to this item: http://hdl.handle.net/10036/11783


Title: Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
Author: Macfarlane, Wendy M.
Frayling, Timothy M.
Ellard, Sian
Evans, Julie C.
Allen, Lisa I. S.
Bulman, Michael P.
Ayres, Susan
Shepherd, Maggie
Clark, Penny
Millward, Ann
Demaine, Andrew
Wilkin, Terence
Docherty, Kevin
Hattersley, Andrew T.
Citation: Journal of Clinical Investigation, 1999, 104(9):R33-R39
Publisher: American Society for Clinical Investigation
Journal: Journal of Clinical Investigation
Date Issued: 1999-11-01
URI: http://hdl.handle.net/10036/11783
Abstract: The transcription factor insulin promoter factor-1 (IPF-1) plays a central role in both the development of the pancreas and the regulation of insulin gene expression in the mature pancreatic beta cell. A dominant-negative frameshift mutation in the IPF-l gene was identified in a single family and shown to cause pancreatic agenesis when homozygous and maturity-onset diabetes of the young (MODY) when heterozygous. We studied the role of IPF-1 in Caucasian diabetic and nondiabetic subjects from the United Kingdom. Three novel IPF-1 missense mutations (C18R, D76N, and R197H) were identified in patients with type 2 diabetes. Functional analyses of these mutations demonstrated decreased binding activity to the human insulin gene promoter and reduced activation of the insulin gene in response to hyperglycemia in the human beta-cell line Nes2y. These mutations are present in 1% of the population and predisposed the subject to type 2 diabetes with a relative risk of 3.0. They were not highly penetrant MODY mutations, as there were nondiabetic mutation carriers 25-53 years of age. We conclude that mutations in the IPF-1 gene may predispose to type 2 diabetes and are a rare cause of MODY and pancreatic agenesis, with the phenotype depending upon the severity of the mutation.
Type: Article
ISSN: 0021-9738
PubMed ID: 10545530
PubMed Central ID: 481047
Rights: Copyright © 1999, American Society for Clinical Investigation

Please note: Before reusing this item please check the rights under which it has been made available. Some items are restricted to non-commercial use. Please cite the published version where applicable.

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)


My Account

Local Links